000 01453 a2200397 4500
005 20250517032616.0
264 0 _c20160310
008 201603s 0 0 eng d
022 _a1532-2513
024 7 _a10.3109/08923973.2015.1035392
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSon, Young Jun
245 0 0 _aImproved efficacy of soluble human receptor activator of nuclear factor kappa B (RANK) fusion protein by site-directed mutagenesis.
_h[electronic resource]
260 _bImmunopharmacology and immunotoxicology
_cJun 2015
300 _a221-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmino Acid Substitution
650 0 4 _aAnimals
650 0 4 _aCHO Cells
650 0 4 _aCricetinae
650 0 4 _aCricetulus
650 0 4 _aHumans
650 0 4 _aImmunoglobulins
_xbiosynthesis
650 0 4 _aMutagenesis, Site-Directed
650 0 4 _aMutation, Missense
650 0 4 _aProtein Structure, Secondary
650 0 4 _aReceptor Activator of Nuclear Factor-kappa B
_xbiosynthesis
650 0 4 _aRecombinant Fusion Proteins
_xbiosynthesis
650 0 4 _aSolubility
700 1 _aHan, Jihye
700 1 _aLee, Jae Yeon
700 1 _aKim, HaHyung
700 1 _aChun, Taehoon
773 0 _tImmunopharmacology and immunotoxicology
_gvol. 37
_gno. 3
_gp. 221-7
856 4 0 _uhttps://doi.org/10.3109/08923973.2015.1035392
_zAvailable from publisher's website
999 _c24900813
_d24900813